**Cold-Pressed, Publicly Traded**

Suja Life just squeezed nearly $200 million out of the public markets. The company sold 8.9 million shares at $21 each, the low end of its $21 to $24 range, raising $186.7 million in its IPO.

Then came the reality check.

Shares opened at $18 and fell 14.3% in their Nasdaq debut, valuing the company at $695.3 million.

Suja Life, the force behind Suja Organic, Vive Organic and Slice Soda, plays squarely in cold-pressed juices, wellness shots and functional sodas. Translation, the better-for-you cooler set. CEO says the IPO proceeds will go toward expanding production and possibly an acquisition. So this is not just about paying down debt or giving early investors an exit. It is about building scale.

Private equity firm Paine Schwartz Partners bought the company in 2021 from Goldman Sachs Asset Management and co-investors. Now the story shifts from sponsor-owned growth to public market scrutiny.

Why it matters. Public investors are signaling that health and wellness is hot, but price still matters. Pricing at $21 and opening at $18 tells you demand was measured. Not euphoric. For other better-for-you brands eyeing the public window, the bar just got clearer.

Quick take. Functional soda and wellness shots may feel trendy, but the market wants proof, not just probiotics. The next chapter for Suja will be less about vibes and more about execution. Expansion and smart M&A could turn that $186.7 million into real shelf dominance. Or it could become an expensive lesson in how crowded the wellness aisle has become.